Please check your internet connection and try again.
# Hyaluronic Acid
## Overview
Hyaluronic acid is a naturally occurring glycosaminoglycan that acts as a viscoelastic agent. It is available in various formulations for different routes of administration.
## Primary Indications
* **Intra-articular injection:** Osteoarthritis of the knee (pain relief).
* **Ophthalmic solution:** Ocular surface protection during surgery, treatment of dry eye symptoms.
* **Topical formulation:** Wound healing, skin hydration.
## Adult Dosing
* **Intra-articular injection (knee osteoarthritis):**
* Typically 2 mL (20 mg) injected intra-articularly once weekly for 3-5 weeks.
* Some products allow for a single injection of 6 mL (60 mg).
* Specific dosing and number of injections can vary by product and local protocol.
* **Ophthalmic solution:**
* 1 drop instilled into the affected eye as needed, or as directed by the prescribing physician.
* Concentrations vary by product (e.g., 0.1%, 0.2%, 1%).
* **Topical formulation:**
* Apply to affected area as directed by the prescribing physician.
## Pediatric Dosing
Dosing for pediatric patients is generally not established or well-studied for most indications. Use with caution and under specialist guidance if considered.
## Dose Adjustments
No specific dose adjustments are typically required for renal or hepatic impairment, as hyaluronic acid is metabolized locally or systemically cleared.
## Contraindications
* Known hypersensitivity to hyaluronic acid or any component of the formulation.
* Infection in or around the injection site for intra-articular preparations.
## Adverse Effects
* **Intra-articular:** Localized pain, swelling, stiffness, redness, warmth at the injection site. Transient joint effusion.
* **Ophthalmic:** Temporary blurred vision, stinging, itching, eye irritation.
* **Topical:** Mild skin irritation.
## Key Drug Interactions
No significant drug interactions are expected with intra-articular or topical hyaluronic acid. Ophthalmic formulations may have interactions with other topical ophthalmic agents; allow for a separation of at least 5 minutes between applications.
## Monitoring
* **Intra-articular:** Monitor for signs of infection or severe inflammatory reactions at the injection site. Assess for pain relief and functional improvement.
* **Ophthalmic:** Monitor for symptom relief and adverse effects.
## Clinical Pearls
* For intra-articular injections, ensure sterile technique.
* Patient education regarding potential transient post-injection flare is important.
* Topical formulations are often used for moisturizing and supporting skin barrier function.
***
**Disclaimer:** This information is intended for healthcare professionals. Always consult the most current prescribing information and relevant literature for complete details before making any treatment decisions. Dosing and indications can vary significantly based on the specific product and patient factors.
